目前用于治疗晚期胆管癌的现有治疗方法的安全性
Tiago Biachi de Castria1,2, Richard D Kim1,2
1Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Expert opinion on drug safety
|December 24, 2024
概括
胆道癌 (BTC) 的全身治疗正在发展,有新的向疗法和免疫疗法可用. 本综述的重点是了解和管理BTC患者这些先进治疗方法的独特毒性概况.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胆道癌 (BTC) 包括肝内胆道癌,肝外胆道癌和胆囊癌.
- 非特异性症状和缺乏查导致大多数BTC患者的晚期疾病呈现和预后不佳.
研究的目的:
- 审查胆道癌 (BTC) 系统治疗的安全性.
- 讨论各种BTC疗法的独特毒性概况,包括化疗,免疫疗法和向药物.
- 提供有关治疗相关毒性管理策略的见解,以改善患者的服药性和耐受性.
主要方法:
- 非系统的文献综述.
- 专注于有关全身疗法及其安全性的高质量文章.
- 分析既定和新兴的治疗方式.
主要成果:
- 2010年,ABC-02试验确立了吉姆西塔/作为高级BTC的第一线化疗方法.
- 现在有多种向疗法 (FGFR2,IDH1,HER2) 和免疫疗法可供使用.
- 了解分子形状对于选择合适的疗法和管理毒性至关重要.
结论:
- 对BTC的系统性治疗正在推进新型治疗选择.
- 管理治疗毒性对于优化患者的治疗结果和治疗坚持至关重要.
- 在BTC中,个性化分子分析指导治疗选择和毒性管理.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.8K
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
14.2K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
